OpenAI’s Plan to Give Everyone Custom Chatbots Drops Next Week
Share- Nishadil
- January 05, 2024
- 0 Comments
- 1 minutes read
- 7 Views
OpenAI has announced the impending launch of an AI marketplace known as the GPT Store, reported first by . This store will feature customizable AI applications or agents. According to OpenAI's CEO, Sam Altman, the GPT Store is part of their plan to make AI more accessible, useful, and personable. Unveiled initially on Nov. 7th at , developers have since created thousands of these AI agents, which can be used for various tasks, from building websites to giving tax advice. These can be operated even without coding skills. The announcement comes amid certain issues surrounding the company, including Altman's surprising departure, occurring last November.
However, the GPT Store's financial model is not clear yet, particularly with the promise to pay top GPT creators. Currently, only ChatGPT Premium subscribers, who pay a $20 monthly subscription, can access the GPTs. With the launch of the GPT Store, this access will be extended to non-paying users. Nevertheless, how OpenAI intends to generate revenue from, this remains unclear. Altman did mention a revenue-sharing model to reward the most talented and successful GPT creators.
The GPT Store could follow Apple's App Store or Google Play Store's models for similarities, but these models have been criticized recently for questionable business practices. Hence, fostering a vibrant, competitive environment is vital as OpenAI has faced past criticism over their handling of product updates.
Another point of concern surrounds security vulnerabilities, as hackers have demonstrated these can be exploited. These weak spots could deter businesses from creating GPT agents. OpenAI has taken steps to address these vulnerabilities, but this could still affect the confidence of potential developers.
Also, the crucial question of the usefulness and efficiency of the GPTs compared to their main AI - ChatGPT – is pending a verdict. We will have to wait to see how these agents perform and whether they truly can outperform their predecessor.